HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Involvement of RhoA/ROCK1 signaling pathway in hyperglycemia-induced microvascular endothelial dysfunction in diabetic retinopathy.

Abstract
Diabetic retinopathy (DR) is a well-known serious complication of diabetes mellitus (DM), and can eventually advance to end-stage blindness. In the early stage of DR, endothelial cell barrier disorganized primarily and tight junction (TJ) protein composition transformed subsequently. The small GTPase RhoA and its downstream effector Rho-associated coiled-coil containing protein kinase 1 (ROCK1) regulate a mass of cellular processes, including cell adherence, proliferation, permeability and apoptosis. Although RhoA inhibitors have provided substantial clinical benefit as hypertonicity therapeutics, their use is limited by complex microenvironment as DR. While ample evidence indicates that TJ can be influenced by the RhoA/ROCK1 signaling, the underlying mechanisms remain incompletely understood. Here, we have uncovered a significant signaling network involved in diabetic retinal microvascular endothelial dysfunction (RMVED). Our results indicated that the activation of RhoA/ROCK1 pathway due to high glucose played a key role in microvascular endothelial cell dysfunction (MVED) by way of directly inducing TJ proteins over-expression during DR. We demonstrated that inhibition of RhoA/ROCK1 may attenuate the hypertonicity of endothelial cell caused by high glucose microenvironment meanwhile. Besides, chemical and pharmacological inhibitors of RhoA/ROCK1 pathway may partly block inflammation due to DR. Simultaneously, the apoptosis aroused by high glucose was also prevented considerably by fasudil, a kind of pharmacological inhibitor of RhoA/ROCK1 pathway. These findings indicate that RhoA/ROCK1 signaling directly modulates MVED, suggesting a novel therapeutic target for DR.
AuthorsQian-Yi Lu, Wei Chen, Li Lu, Zhi Zheng, Xun Xu
JournalInternational journal of clinical and experimental pathology (Int J Clin Exp Pathol) Vol. 7 Issue 10 Pg. 7268-77 ( 2014) ISSN: 1936-2625 [Electronic] United States
PMID25400825 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Protein Kinase Inhibitors
  • rho-Associated Kinases
  • rhoA GTP-Binding Protein
  • Glucose
Topics
  • Animals
  • Apoptosis
  • Capillary Permeability
  • Cell Line
  • Cellular Microenvironment
  • Diabetic Retinopathy (enzymology, etiology, pathology, physiopathology)
  • Electric Impedance
  • Endothelial Cells (drug effects, enzymology, pathology)
  • Glucose (metabolism)
  • Hyperglycemia (complications, enzymology)
  • Macaca mulatta
  • Microvessels (drug effects, enzymology, pathology, physiopathology)
  • Protein Kinase Inhibitors (pharmacology)
  • RNA Interference
  • Retinal Vessels (drug effects, enzymology, pathology, physiopathology)
  • Signal Transduction (drug effects)
  • Tight Junctions (enzymology)
  • Transfection
  • rho-Associated Kinases (antagonists & inhibitors, genetics, metabolism)
  • rhoA GTP-Binding Protein (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: